Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T18:52:30.067Z.
Calculation as of: 2026-10-06T18:52:30.067Z.
Quote observation: 2026-10-06T18:50:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7a3ccde1bd0df5c55ebc0148063105fff0bf751cb52a3071af3e3331f6001fbe
PEG RATIO
N/A
Market Cap
$500.75M
PEG Ratio
N/A
TTM Avg
5.21
3Y Avg
2.88
5Y Avg
2.88
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $495.39M | N/A | N/A | N/A | N/A |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.75M | N/A | 5.21 | 2.88 | 2.88 |
| Puma Biotechnology, Inc. (PBYI)vs › | $488.68M | N/A | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.75M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $507.38M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $510.29M | N/A | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $511.66M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $475.19M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $474.59M | N/A | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $474.22M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
